A Study to Evaluate the Safety, Tolerability and Efficacy of Cabozantinib in Patients With Hepatocellular Carcinoma and Impaired Liver Function
Clinical trial NCT04454762 · UNKNOWN
Trial details
- NCT number
- NCT04454762
- Sponsor
- Johannes Gutenberg University Mainz
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-22
- Primary completion
- 2023-08-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.